|
TNPO3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.276700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.203400E-01 |
| Normal-vs-Stage2 |
1.827390E-01 |
| Normal-vs-Stage3 |
4.544200E-02 |
| Normal-vs-Stage4 |
2.973400E-01 |
| Stage1-vs-Stage2 |
2.571200E-01 |
| Stage1-vs-Stage3 |
1.950410E-01 |
| Stage1-vs-Stage4 |
6.440400E-01 |
| Stage2-vs-Stage3 |
5.455400E-01 |
| Stage2-vs-Stage4 |
4.231800E-01 |
| Stage3-vs-Stage4 |
6.956000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.659610E-02 |
| Normal-vs-AfricanAmerican |
2.101600E-01 |
| Normal-vs-Asian |
3.123600E-01 |
| Caucasian-vs-AfricanAmerican |
8.167000E-01 |
| Caucasian-vs-Asian |
5.015400E-01 |
| AfricanAmerican-vs-Asian |
7.363000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.172590E-01 |
| Normal-vs-Female |
3.024300E-03 |
| Male-vs-Female |
2.205700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.343600E-01 |
| Normal-vs-Extreme_Weight |
5.984400E-01 |
| Normal-vs-Obese |
4.406400E-02 |
| Normal-vs-Extreme_Obese |
7.263400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.795200E-01 |
| Normal_Weight-vs-Obese |
2.883000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.772800E-01 |
| Extreme_Weight-vs-Obese |
1.156250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.898600E-01 |
| Obese-vs-Extreme_Obese |
5.311400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.434410E-02 |
| Normal-vs-Age(41-60Yrs) |
3.019000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.526800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.870000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.757000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.301770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.902600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.935620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.492400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.065200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.200100E-02 |
| Normal-VS-Type2 PRCC |
1.041360E-01 |
| Normal-VS-KIRP CIMP |
2.713800E-01 |
| Normal-VS-Unclassified PRCC |
5.192400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.272200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.720600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.881800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.371600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.562000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.639000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.040600E-01 |
| Normal-vs-N1 |
1.017690E-02 |
| Normal-vs-N2 |
7.332600E-01 |
| N0-vs-N1 |
1.954050E-02 |
| N0-vs-N2 |
9.042400E-01 |
| N1-vs-N2 |
3.336600E-01 |
|
|
